Changes in Beneficial Ownership · 4
Sight Sciences, Inc.
SGHTNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
ownership.xml
Filing details
- Report period
- 2026-08-10
- Issuer
- Sight Sciences, Inc.
- Issuer CIK
- 0001531177
- Trading symbol
- SGHT
Reporting owner 1
- Name
- Rashid Kashif
- Reporting owner CIK
- 0001725900
- Relationship
- Officer
- Officer title
- Chief Legal Officer
- Address
- C/O SIGHT SCIENCES, INC., 4040 CAMPBELL AVE., SUITE 100, MENLO PARK, CA, 94025
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2026-08-10 | A · Form 4 | 181,818[F1] | A | 0.00 | 181,818 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Footnotes
- F1
- Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan (the "2021 Plan"). The RSUs vest in four equal annual installments commencing August 10, 2027 and continuing through August 10, 2030, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share.↩ 1
Signature 1
- Signed
- /s/Kashif Rashid
- Date
- 2026-08-18
Company context
Sight Sciences is an eyecare technology company focused on developing and commercializing innovative and interventional solutions intended to transform care and improve patients’ lives. Using minimally invasive or non-invasive approaches to target the underlying causes of the world’s most prevalent eye diseases, Sight Sciences seeks to create more effective treatment paradigms that enhance patient care and supplant conventional outdated approaches. The Company’s OMNI® Surgical System is an implant-free, minimally invasive glaucoma surgery technology indicated in the United States to reduce intraocular pressure in adult patients with primary open-angle